Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. - Test2 - elhamkhani - TriplyDB

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

http://www.wikidata.org/entity/Q24657796

about

Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption Depression as a Glial-Based Synaptic Dysfunction Exploring exercise as an avenue for the treatment of anxiety disorders Ostracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder--was this a correct decision? A literature review Regulation of fear responses by striatal and extrastriatal adenosine A2A receptors in forebrain.Isoflurane preconditioning and postconditioning in rat hippocampal neurons.Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.Membrane cholesterol access into a G-protein-coupled receptor.Potential link between caffeine consumption and pediatric depression: A case-control study Substructure-based virtual screening for adenosine A2A receptor ligands.Wheel running alters patterns of uncontrollable stress-induced cfos mRNA expression in rat dorsal striatum direct and indirect pathways: A possible role for plasticity in adenosine receptors Targeting the dopamine D3 receptor: an overview of drug design strategies.Adenosine A1, but not A2, receptor blockade increases anxiety and arousal in Zebrafish.Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.Adenosine A₂A receptors in striatal glutamatergic terminals and GABAergic neurons oppositely modulate psychostimulant action and DARPP-32 phosphorylation.ATP as a multi-target danger signal in the brain.Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum.Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders Comorbidities in Neurology: Is adenosine the common link?Caffeine increases psychomotor performance on the effort expenditure for rewards task.Functional interaction between pre-synaptic α6β2-containing nicotinic and adenosine A2A receptors in the control of dopamine release in the rat striatum.The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function.Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.Oroxylin A Induces BDNF Expression on Cortical Neurons through Adenosine A2A Receptor Stimulation: A Possible Role in Neuroprotection Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction.Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.The role of adenosine in Alzheimer's disease Adenosine neuromodulation and traumatic brain injury.Neurotransmission in Parkinson's disease: beyond dopamine.The role of extracellular adenosine in chemical neurotransmission in the hippocampus and Basal Ganglia: pharmacological and clinical aspects.Future research directions in sleep and ADHD: report of a consensus working group.Moonlighting adenosine deaminase: a target protein for drug development.Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.How does adenosine control neuronal dysfunction and neurodegeneration?Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues.The RS685012 Polymorphism of ACCN2, the Human Ortholog of Murine Acid-Sensing Ion Channel (ASIC1) Gene, is Highly Represented in Patients with Panic Disorder.Radiation Dosimetry of a Novel Adenosine A2A Receptor Radioligand [11C]Preladenant Based on PET/CT Imaging and Ex Vivo Biodistribution in Rats.Putative genes mediating the effects of orexins in the posterior paraventricular thalamus on neuroendocrine and behavioral adaptations to repeated stress

P2860

Q24602048-D91BC380-79EE-4B11-ABD2-BF3E78FE12DE Q26772830-4B8A23D5-A289-4101-AB91-EAC526082EBB Q27001236-CA8B2D85-FEB4-4C82-940C-51C46A7F4756 Q28243209-155C18D8-0450-4FAD-8062-3F32ED93D832 Q30423837-6C86F387-9BE4-4666-A7A8-4D1D693EF164 Q30430142-BC1D8664-041E-4C7B-9D18-BD70B0D9F32A Q30482913-E0FC48D9-9F22-4489-A349-25D47066F236 Q30839707-B20B88A0-32BE-49CC-9796-182C9DE1FE02 Q34002916-30FFDB23-A428-4107-9FA4-5CD3E9C2B042 Q34054895-F6DDD855-0108-4E36-9966-A6142BC91077 Q34337032-C719DD06-8929-452C-86D6-C19F1480C48E Q34524556-88D9A514-9285-449B-A3EE-B165F5B36941 Q34628537-BAE5EB9A-0AB1-4898-9B2D-6AE5B45E9BCA Q34674792-D625A36C-CDDD-462F-BCC8-B67581319C04 Q35060382-4F8048DA-9E15-4B7A-8DD6-B76ACD9452CF Q35545478-4B2EBD0E-49EA-49C4-B81C-CE390E34B745 Q35587857-126683E6-F9E6-4189-B5A3-59E5C7750DD2 Q35917127-E4B23998-56F9-4F01-8C86-CBFDB0547879 Q35951700-24953132-B4A1-4421-B851-5F088C821897 Q35956389-93EB5387-7ECC-40D4-8C92-84271C816094 Q36626809-9ACF2D6F-99CA-495D-99AE-BEE795934450 Q37046788-921C459D-745B-420F-9C51-9BDA84B0A90D Q37131954-370DBEFA-1D51-4376-A6CD-B3227B85A300 Q37166542-3455E6FA-C636-484B-8932-785E887D53CC Q37206467-8400F394-48B3-4C6A-8166-00C55D02D620 Q37219383-1242C6C2-65EE-4EE3-9A92-D7E0268323A3 Q37298281-C0817AA2-4E92-4382-8A65-34985273C513 Q37358974-6F4B8B1A-3EA7-46CF-A8E9-3A4198D35D1A Q37402673-E49CD408-3A2E-4781-8EE0-2A0931FFE885 Q37402676-DD3CB6E5-8AF6-47D1-A476-91BE56712578 Q37668684-2A791372-7647-4649-9BF1-BD33723EDE31 Q37852727-AE8A1854-C538-46E0-8C08-C70774D2DD86 Q38043889-464F01FC-1B6C-4B0E-8C48-EFE91ECF6054 Q38220597-F612BA33-DEE6-4B6D-87B2-62E40110850E Q38358456-72725AF3-198B-4C40-9829-3F862DA41C81 Q38882782-92CE9FD4-DECE-464E-8DC9-C16A4877557E Q38907149-74A2AAD4-23EB-482E-80AE-C3CB0C8408EF Q38940622-8F4D631B-6622-4DC0-AF70-1F5185F80C64 Q39475901-644A7B2B-B757-4DE9-B9A9-859A08FC416B Q41069950-E67FA8D7-6908-4A81-84DC-CFB81FC87DE0

P2860

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

http://www.wikidata.org/entity/Q24657796

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders

@nl

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@ast

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@en

type

label

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders

@nl

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@ast

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@en

prefLabel

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders

@nl

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@ast

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@en

P1433

Q24657796-D9A7BF33-FAEE-414A-9388-2ACFD58627A0

P1476

Q24657796-75589794-ABBD-44E2-8500-740C32C39C0C

P2093

Q24657796-49FD0D89-65A9-4073-90BF-BD839D153643

Q24657796-7348352A-BC45-40A2-A963-AB0C3E1D6064

Q24657796-F4BB17E9-8A90-4CF7-915A-BCEC7AA5E3D4

P2860

Q24657796-052C98FB-5221-4C56-BE5D-CBF5BCEB8545

Q24657796-074FD420-D9E0-4F57-987D-26B93D02DACF

Q24657796-09F2847E-9212-4D45-ACCA-476E6B6B2404

Q24657796-0A5018FD-A5F1-4C4F-BC0F-4B645C04C967

Q24657796-0A9823F9-7DE6-4C42-8A4E-A0C16D078399

Q24657796-0AFA9655-D0F7-4F5B-8187-CDD6A10598D1

Q24657796-0BBBB017-87BE-4C74-91C6-D71456545674

Q24657796-0C99DD4E-55D4-4D43-B4DB-F009EE22B1CC

Q24657796-0CDAC6DA-9C1B-444F-A207-8316C2906A63

Q24657796-0D779BD1-5E23-4AB1-B47F-0F6FE268C984

P304

Q24657796-69AEE198-689C-42D1-B388-39F45CE6A5C3

P31

Q24657796-AC971080-BFFE-4344-9E47-042A27FBA6F8

P3181

Q24657796-182E3076-90AB-4894-969E-41F2BDE33869

P356

Q24657796-4525B7AA-D0D3-4025-9C56-70A021110F9B

P407

Q24657796-1925178D-BBDF-42EF-897A-ED0BAF5618E8

P433

Q24657796-F8ED5299-B6F6-414D-9A2E-1C3772795580

P478

Q24657796-83DA35B8-8D4F-47BC-BD20-D97E4B7CF4EB

P50

Q24657796-188F28EA-3E4E-4660-8327-82E8AB5D8E51

Q24657796-5BCB3D04-A267-48A2-AB0B-DDC3053E5E9E

P577

Q24657796-7FF9850F-9266-44E1-A281-B58E11248F02

P5875

Q24657796-EAAE79D0-3B96-46C5-B3D5-8BFB4D19DB37

P698

Q24657796-F9CB4C59-1F0E-4B1F-AF1C-7D4F04ED5C43

P932

Q24657796-2EAAE4DE-2FE5-45E6-880C-D4AB90237A68

P3181

P356

138161208784480090

P1433

Current Pharmaceutical Design

P1476

Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

@en

P2093

Jean-Marie Vaugeois

http://www.w3.org/2001/XMLSchema#string

Jiang-Fan Chen

http://www.w3.org/2001/XMLSchema#string

Sergi Ferré

http://www.w3.org/2001/XMLSchema#string

P2860

Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

Neurobiology of depression: an integrated view of key findings

Adenosine A2A receptors and basal ganglia physiology

Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia

Potentiation of the action of adenosine on cerebral cortical neurones by the tricyclic antidepressants

Adenosine A2A receptors and depression

Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors

P304

1512-1524

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4009252

http://www.w3.org/2001/XMLSchema#string

P356

10.2174/138161208784480090

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Rodrigo A. Cunha

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5319201

http://www.w3.org/2001/XMLSchema#string

P698

18537674

http://www.w3.org/2001/XMLSchema#string

P932

2423946

http://www.w3.org/2001/XMLSchema#string